Sunfox Technologies

Rajat Jain (Founder & CEO) is the product architect, company visionary, and personal bridge between the mission (preventing cardiac deaths in underserved communities) and the commercial vehicle (building a globally competitive medical device company from a Tier-2 city). His Graphic Era University biomedical engineering background gave him the technical foundation; his village upbringing and the loss of his 21-year-old friend gave him the mission urgency that no business school programme can manufacture. Saurabh Badola (Software Lead), Nitin Chandola (Technical Lead), and Sabit Rawat (Marketing Lead) form the operational and technical core — three co-founders with complementary expertise covering the full product stack from hardware engineering to software development to market access. The company is supported by Graphic Era University, Dehradun and is a part of the Startup India initiative.

Spandan is the world's most affordable clinical-grade portable 12-lead ECG device — a 12–14 gram device that connects to any Android or iOS smartphone, delivers a complete 12-lead ECG in under 30 seconds with 99.7% clinical accuracy, requires no battery and no internet connection to function, detects heart attack symptoms, arrhythmias, and cardiac abnormalities, and produces ECG traces that can be zoomed up to 50x — making hospital-quality cardiac diagnostics available anywhere in the world, from a village health centre to a first responder's kit to a family's home.

Amount Asked: ₹1 crore Equity Offered: 2% Implied Pre-Money Valuation: ₹50 crore

Spandan's pitch was the second of Episode 25 — arriving after PawsIndia's pet care marketplace with something that shifted the episode's register entirely: a matter of life and death. Rajat Jain walked into the Tank with a device the size of a matchbox that could detect a heart attack in 30 seconds on a smartphone, and opened with the statistic that 20 lakh Indians die of cardiac arrests every year. All the Sharks from Peyush Bansal to Namita Thapar were impressed by the revolutionary product of Sunfox Technologies. Peyush Bansal called the product revolutionary. Vineeta Singh and Ghazal Alagh also went gaga over the product's astonishing features. In a poignant moment, Ghazal shared an incident of a relative who died of cardiac arrest while talking about the necessity of prompt medical diagnosis and treatment. The live demonstration — performing an ECG on one of the team members using the device connected to a smartphone, with the trace appearing on screen in under 30 seconds.

All five Sharks wanted to invest — and moved quickly to a collective offer rather than competing individually. The unanimous enthusiasm reflected the convergence of mission (preventing cardiac deaths), technology (clinical-grade ECG from a matchbox), market (2 million annual Indian cardiac deaths), and founder credibility (performing ECG on his own father). Namita shared in a post that the company has also launched five groundbreaking products since its inception. Namita's post-show public praise for Spandan — a Shark who is a pharma industry insider and therefore the most medically credible evaluator on the panel — is the most expert-validated endorsement of the product's clinical merit.

Then the Sharks straight got to the main point by offering an 'all-Sharks' joint deal for 6% equity. In the end, all 5 Sharks — Peyush Bansal, Vineeta Singh, Namita Thapar, Ghazal Alagh and Anupam Mittal — closed the deal for ₹1 crore for 6% stakes in the company. The negotiation was the shortest and most decisive of any All-Shark deal in Season 1 — the Sharks moved directly to a collective offer rather than competing individually, and the equity movement from 2% (founders' ask) to 6% (deal) was accepted without extended back-and-forth. The founders correctly identified that five Sharks' networks across healthcare, pharmaceuticals, D2C distribution, and digital platforms were worth the 4 percentage point equity cost.

Deal Secured: YES — CONFIRMED AND FORMALLY CLOSED (All-Five-Shark deal) Deal Status:- Confirmed & Formally Closed Investment Amount:- ₹1 crore Equity Given:- 6%